Andreas Hadjimichael is 10% Owner at Karyopharm Therapeutics Inc. (KPTI). They have made 12 open-market trades across 2 companies since 2014, most recently 2022-11-17.
CIK 0001591256
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2022, against 11 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 45% | 55% |
| Avg Move | -10.5% | -0.2% | -2.7% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRV | BUY | 2022-11-17 | 2022-11-21 | $12.50 | $5.0M | -5.2% | -10.7% | +37.2% |
| KPTI | SELL | 2019-02-25 | 2019-02-27 | $4.73 | $9.6M | -10.0% | +27.5% | +26.6% |
| KPTI | SELL | 2018-07-19 | 2018-07-23 | $18.97 | $4.8M | -5.1% | -2.1% | -35.7% |
| KPTI | SELL | 2016-06-23 | 2016-06-27 | $8.03 | $302K | +1.3% | +9.3% | +33.2% |
| KPTI | SELL | 2016-05-23 | 2016-05-23 | $8.77 | $298K | +5.1% | -12.7% | -11.8% |
| KPTI | SELL | 2016-05-23 | 2016-05-23 | $8.77 | $298K | +5.1% | -12.7% | -11.8% |
| KPTI | SELL | 2016-05-20 | 2016-05-23 | $8.52 | $341K | +5.1% | -12.7% | -11.8% |
| KPTI | SELL | 2016-05-19 | 2016-05-23 | $8.18 | $164K | +5.1% | -12.7% | -11.8% |
| KPTI | SELL | 2016-05-10 | 2016-05-12 | $8.29 | $362K | +18.5% | +5.0% | -15.8% |
| KPTI | SELL | 2014-11-04 | 2014-11-06 | $42.11 | $11.5M | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-09-24 | 2014-09-26 | $40.32 | $907K | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-08-26 | 2014-08-28 | $38.80 | $1.7M | -46.9% | +3.0% | +3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.